All terms in HP
| Label | Id | Description |
|---|---|---|
| regulation of heme biosynthetic process | GO_0070453 | [Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of heme.] |
| negative regulation of heme biosynthetic process | GO_0070454 | [Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of heme.] |
| positive regulation of heme biosynthetic process | GO_0070455 | [Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of heme.] |
| dacrystic epilepsy | NBO_0000739 | |
| epilepsy | NBO_0000642 | |
| gelastic epilepsy | NBO_0000738 | |
| hypocalcemia induced seizure | NBO_0000735 | |
| provoked seizure | NBO_0000686 | |
| photostimulation induced seizure | NBO_0000737 | |
| hemiclonic seizure | NBO_0000731 | |
| simple partial seizure with motor signs | NBO_0000651 | |
| Abnormality of glycosaminoglycan metabolism | HP_0004371 | [Abnormality of glycosaminoglycan metabolism.] |
| lysinium(2+) | CHEBI_32565 | [An alpha-amino-acid cation obtained by protonation of both amino groups of lysine.] |
| polychromatophilic cytoplasm | CP_0000035 | [Cytoplasm that exhibits affinity for both basic and acid stains under specific pH conditions.] |
| increased nucleus size | CP_0000037 | [A nucleus size quality which is relatively high compared to the amount of cytoplasm present in the same cell.] |
| Decreased urine output | HP_0011037 | [A decreased rate of urine production.] |
| histidinium(1+) | CHEBI_32531 | |
| histidine | CHEBI_27570 | [An alpha-amino acid that is propanoic acid bearing an amino substituent at position 2 and a 1H-imidazol-4-yl group at position 3.] |
| histidinium(2+) | CHEBI_32532 | |
| copulation phenotype | NBO_0000762 |